Paul McBarron
Finanzdirektor/CFO bei CYCLACEL PHARMACEUTICALS, INC.
Vermögen: 25 986 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Paul McBarron
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 26 | |
Cyclacel Group Plc
 Cyclacel Group Plc Pharmaceuticals: MajorHealth Technology Cyclacel Group Plc designs and develops small molecule drugs. The company developed small molecule drugs act on key cell cycle regulators to stop uncontrolled cell division in cancer and other diseases involving abnormal cell proliferation. Cyclacel Group Plc was founded by Professor Sir David Lane in 1996 and is headquartered in Dundee, UK.
9
| Extinct | Pharmaceuticals: Major | 9 |
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Paul McBarron
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin | |
Fred Hutchinson Cancer Research Center
 Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Fred Hutchinson Cancer Research Center is a non-profit organization which provides research and testing services. The company was founded in 1965 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Maze Therapeutics, Inc.
 Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ARQULE, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Private Equity Investor | |
The Cancer Institute of New Jersey
 The Cancer Institute of New Jersey Hospital/Nursing ManagementHealth Services The Cancer Institute of New Jersey operates as a cancer centre. The firm offers cancer care for adults and children, providing access to the medicines and treatment options. It also offers clinical, patient education resources and support services. The company was founded in and is headquartered in New Brunswick, NJ. | Hospital/Nursing Management | Director/Board Member Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| OMEROS CORPORATION | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| AFFYMAX, INC. | Biotechnology | Director/Board Member Comptroller/Controller/Auditor | |
| ANTHERA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| PROTHENA CORPORATION PLC | Biotechnology | Director/Board Member Comptroller/Controller/Auditor | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Cambridge | College/University | Undergraduate Degree Undergraduate Degree | |
Aton Pharma, Inc.
 Aton Pharma, Inc. Pharmaceuticals: MajorHealth Technology Aton Pharma, Inc. develops therapeutics for cancer and other diseases. Its products include Edecrin, Sodium Edecrin, Cuprimine, Demser and Syprine. The company was founded by Michael G. Wells in 2001 and is headquartered in Lawrenceville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Pharmaceuticals: Other | Founder President | |
| Stevens Institute of Technology | College/University | Undergraduate Degree Undergraduate Degree | |
| Yale University | College/University | Doctorate Degree Undergraduate Degree | |
| The Johns Hopkins University | College/University | Doctorate Degree Corporate Officer/Principal | |
Iroko Pharmaceuticals LLC
 Iroko Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Iroko Pharmaceuticals LLC develops and distributes pharmaceutical products. It provides approved US products, marketed global, medical information and product patents. The company was founded in 2007 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Kellogg School of Management | College/University | Graduate Degree Graduate Degree | |
| ARIX BIOSCIENCE PLC | Investment Managers | Director/Board Member Director/Board Member | |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Aventis, Inc. | Corporate Officer/Principal | ||
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| TOBIRA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
| POXEL | Pharmaceuticals: Major | Chairman | |
| NEPHROGENEX INC | Medical Distributors | Chief Executive Officer | |
Stone Management LLC
 Stone Management LLC Miscellaneous Commercial ServicesCommercial Services Stone Management LLC provides management services. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Hoechst Marion Roussel, Inc. | Director of Finance/CFO | ||
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
| McGill University | College/University | Masters Business Admin | |
Semprae Laboratories, Inc.
 Semprae Laboratories, Inc. Medical/Nursing ServicesHealth Services Semprae Laboratories, Inc. provides consumer products for female sexual health. The company was founded by Rachel Braun Scherl and Mary Wallace Jaensch in 2008 and is headquartered in San Diego, CA. | Medical/Nursing Services | Chairman | |
MAKScientific LLC
 MAKScientific LLC Pharmaceuticals: MajorHealth Technology MAKScientific LLC develops drugs to treat medical disorders by modulating the endocannabinoid system. The firm discovers medications for metabolic disorders, pain, addiction, and neurological diseases. The company was founded by Alexandros Makriyannis in 2004 and is headquartered in Mystic, CT. | Pharmaceuticals: Major | Director/Board Member | |
Eckerd Corp.
 Eckerd Corp. Drugstore ChainsRetail Trade Part of Rite Aid Corp., Eckerd Corp. is a company that owns and operates drugstores. The company is based in Largo, FL. | Drugstore Chains | Chief Executive Officer | |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 42 |
| Vereinigtes Königreich | 5 |
| Kanada | 4 |
| Irland | 2 |
| Frankreich | 2 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 9 |
| Commercial Services | 5 |
| Finance | 4 |
| Health Services | 3 |
Operativ
| Director/Board Member | 309 |
| Independent Dir/Board Member | 90 |
| Corporate Officer/Principal | 76 |
| Chairman | 47 |
| President | 33 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Robert Nelsen | 80 |
| David C. U'Prichard | 49 |
| Pierre Legault | 45 |
| Simon Gibbins | 40 |
| Robert Spiegel | 30 |
| Stephen Neal Wertheimer | 26 |
| Dan Spiegelman | 24 |
| John Banham | 23 |
| Suzanne Bruhn | 18 |
| Christopher Henney | 18 |
| David Colpman | 15 |
| Barry James Price | 14 |
| Angus Russell | 14 |
| Samuel Barker | 13 |
| Ronald Berenson | 13 |
- Börse
- Insiders
- Paul McBarron
- Unternehmensverbindungen
